NATASHA WILLIAMSON: Open Payments
NPI 1386033132 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 75 payments from 18 companies in 2025. Trend: 2023 $595 · 2024 $1,154 · 2025 $1,434
Food & beverage: $1,434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $785 |
| Novo Nordisk Inc | 10 | $155 |
| Amgen Inc. | 4 | $76 |
| PFIZER INC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: SKYRIZI, RINVOQ, CREON, QULIPTA, OTEZLA, LINZESS, Wegovy, Rybelsus.
Industry payments across GA — which companies pay providers there.
